Member Info for HereforHemo

Wasn’t going to post again but after reading some of the comments today I thought I’d throw one more in.
Firstly I’ll tell you one thing, after seeing the recent job vacancies at Hemogenyx one thing is clear, the FDA discussions have gone well. There WILL be an IND submitted soon for CAR-T and it’s my view Hemogenyx are extremely confident it’ll be approved and they’ll move into clinical trials. That IS the inflection point and everything else at the moment is irrelevant. Secondly reference Mr India. He won’t sell anything. He hasn’t got the balls to. Unfortunately he’ll end up making money like the rest of us. Personally I’d ignore everything he says as he’s an emotional mess and full of ****. For the sensible, hold, top up when you can as we’re nearly there. Great times ahead. Tick tock.

JHFH you’re right about one thing, posting on here is pointless so that’s me done. C ya.

Just expanding on JHFH’s excellent post, my thoughts…

Hemogenyx have confirmed they are fully funded to take their product candidates forward into human clinical trials and complete proof of concept with over £6.8m cash in the bank. Lead product candidates are as follows:

HEMO CAR-T: Hemogenyx are at an advanced stage of completing their application for an Investigational New Drug (IND). Hemogenyx expect to be in a position to commence human clinical trials as soon as IND designation has been granted. As the chairman stated that clinical trials are expected to commence ‘in a matter of months’ it is my understanding that their IND application is imminent.

CBR: Is a highly valuable new method of creating immunotherapy treatments to treat any viral infection (this is sometimes referred to as ‘Disease X’) and is a totally unique approach in the treatment of blood disorders. Hemogenyx believe the technology will attract interest from a wide range of partners.

CDX: Following a valuable contribution in the development of the HEMO CDX antibody from Eli Lilly, for which Hemogenyx have an exclusive worldwide license, Hemogenyx believe there will be significant interest from financial and strategic partners to take the asset forward into animal toxicity studies and clinical trials.

It is worth noting that Hemogenyx have IP protection for all of the above, as well as Hu-PHEC, which is yet another product candidate with huge potential. With the exception of elements of CDX, Hemogenyx have full ownership of all their product candidates.

It has been confirmed that Hemogenyx have now moved into their new purpose built laboratory and now have the capability to develop and manufacture their own drugs, such as CAR, as well as providing this service to other companies,which will save them substantial amounts of money on outsourcing as well as potentially providing an early revenue stream. To this end they are looking to double their scientific workforce within two years.

In summary Hemogenyx are now on the verge of an inflection point, moving from an R&D pre-clinical company to a fully fledged clinical company in a matter of months, with their product candidates becoming twenty to thirty times more valuable than they are now once proof of concept is achieved later this year.

All of the BOD are heavily invested with the Chairman, Sir Marc Feldmann even taking the majority of his salary in shares and is worth noting that Hemogenyx are collaborating with world leading companies and organisations and some of the best scientists in the world in their field, especially in the development of HEMO CAR-T and CDX.

I believe a very exciting year is ahead for investors as at least one if not two product candidates will enter human clinical trials in the near future. I think it’s reasonable to expect the market capitalisation of Hemogenyx to rise between three and five fold over the coming months.

DYOR.

I hate to say I told you so but I’ve posted of late that they were already in their new laboratory, and that they were cash rich and had between 5-7m in their bank account and were fully funded through to clinical proof of concept for CAR-T, and moving into a laboratory with CAR manufacturing capability whilst employing new staff specialising in CAR manufacturing was a very good sign Hemogenyx were extremely confident of HEMO CAR-T moving into and through clinical trials and the latest results have confirmed all of the above. So rather than say ‘I told you so’ I’ll just say be careful who you listen to on this board. From what I’ve read in the results I’m now very confident that as of today Hemogenyx are undervalued by a massive 33% as they should be trading with a Mcap of £21m. I expect that gap to close next week when investors realise what has actually been said, could even jump by that on Tuesday. Furthermore, I’m very confident that the IND application for CAR-T will be submitted next month and trials will begin either June or July. In my opinion they definitely will become a clinical company in the very near future and valuations then will be above a 40m Mcap, probably substantially above. The good news is CDX might not be too far behind and with two product candidates entering the clinic Hemogenyx enter a different level with institutional investors entering the party. We are actually entering the inflection point we all expected last year. The pain is nearly over and profit awaits all those who have had the courage, tenacity and mental strength to hold through challenging times. As I’ve stated before, there’s not long to wait now. Personally I’m more bullish than ever. The future’s bright, the future’s HEMO. GLA and don’t take my word for it, take an hour of your time and research Hemogenyx. Vlad does **** me off at times with his attitude but I’m absolutely sure of one thing…he’s going to (finally) deliver.

Darien Personally I think anyone in for a quick trade who panics and sells for a loss before the said news is released is going to get little sympathy. In fact it’s highly amusing as said individuals are highly likely to be locked out first thing Tuesday as investors contemplate excellent results. A company valued today at a mcap of £21m yet trading at £15m. Us LTHs are locked and loaded. Live and learn my friend lol.

Think it’ll come after hours Micky. My thoughts, what I’d give for a hostile takeover offer to show Vlad the exact same respect he’s shown all LTH’s.

The last thing any small cap wants to do in this current climate is to try to raise funds. That’s why I’m so bullish on HEMO. My understanding, as of last week, is that Hemogenyx remain cash rich. They have more than enough money to prove clinical proof of concept for CAR-T. Vlad has constantly stated they do NOT require any placing. My expectation as it they’ll have between 5-7m in cash sitting in their bank account. Once this is confirmed it’s IND application next month and clinical trials shortly after. Just my opinion but this will at least bag this quarter. DYOR.

Nobody can predict the Mcap at the moment. As soon as Vlad starts saying what me means along with meaning what he says then we should fly. Far too often he’s promised and under delivered, certainly with regards to timescales, the move to the new lab ‘in days maybe weeks’ being the latest example. However, all can be put right with an IND application for CAR-T next month, and a licensing agreement for CDX and a partner announcement for CBR in approximately the same timeframe. IF they start releasing news in a timely fashion then pretty soon we should hit a mcap of £50m sooner rather than later, but I would put the emphasis on IF. That being said if it wasn’t if but when nobody would haytye fantastic entry price you can get today. DYOR.

Pingu interesting turn of phase because that’s exactly what Vlad said to me ‘trust the science and back the jockey’ and I do!

Everyone is just giving their personal opinion and I have no problem with that. We’ll soon know who’s right but rest assured there will be at least one RNS this week!

Morning Pingu, always good to read your posts. However I don’t think you should be saying things like an SP tidal wave is coming, it’s completely inappropriate. I think an SP tsunami is a far better description lol. GLA.

Mr India Please refer to previous financial statements, you will find there is a great level of detail outlined for all of their product candidates and the same will apply this year. I know they are actually working on them and have been for a while and I know they’ll definitely be out this week, not least because it’s a legal responsibility to do so.

Morning dhub I understand they have moved. Product candidate updates this week along with financials, FDA time in May, finally entering a news rich period. Another Ebola outbreak so great time to get the latest on CBR. Tick tock.

Mr I Probably traders like Earl who bought in based upon nothing but a tweet from Vlad stating Hitlers birthday lol. Don’t take it personally, there are some real imbeciles about.

Patent applications approved and IP fully protected for Hu-PHEC, CAR-T and CDX (although other CDX dual applications with Eli Lilly still awaiting approval).

Get it into your heads, the dates Vlad posted mean nothing in relation to HEMO. I think the next news we’ll get is the end of year financials next week and I expect them to be good, clarifying there is more than enough money in the bank to prove clinical proof of concept for CAR-T, and put an end to the stupid talk of any placing required, because there isn’t.

Mr India Wait until the end of the quarter and thank me then lol. By the way, I expect over 3p by then.

Mr India Of course we’re all frustrated with the SP and the vast majority of us are underwater. The difference is we don’t moan about it, we accept personal responsibility as we pressed try but button. Focus on the fact’s. My understanding is that they are in the new laboratory, they are working towards major announcements, one of which will be their CAR-T IND application. I am fully confident they’ll soon become a clinical company. It’s NOT going to take 2 years. You’ll have your money back this quarter. In my opinion anyway. Relax.

Mr I I don’t know how many times Vlad has eluded to the fact his tweets are personal and nothing to do with business but it’s many. You clearly have no patience and bounce up and down based purely on emotion, as such investing or let’s call it what it really is with small caps is clearly not for you. I suggest you wait a little longer, get your money back, sell up and put it in a piggy bank where it belongs. Think you’ll find that far less stressful.

For those who expect news in the morning, don’t. My interpretation of Vlads tweets.

He asks why so many bad people are born in April.

He tweets April 22nd, a certain Mr Lanza was born and he shot and killed 27 school children.

He tweets April 20th, the date a certain A Hitler was born.

Anyway that’s my take and if you’re reading Vlad please stop ****ing about and deliver some tangible news to put your shareholders out of their suffering!